Sign in
4

Changes in Ownership

Black Diamond Therapeutics, Inc. Filed Acc 0001415889-22-012796

Director acquired 7,167 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DIXON WENDY L · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-12-16 Grant or award : show line 1 in the form +7,167 $1.50 $10,751 16,216 D
Loading xslF345X03/form4-12202022_021201.xml…